Serum sickness and severe angioedema following rituximab therapy in RA

International Journal of Rheumatic Diseases

Volumn 15, Issue 1, 2012, Pages

  Kumar, Ashok ^a   Khamkar, Kundan ^a   Gopal, Hemant ^a  

^a FORTIS HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; CREATININE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; ETANERCEPT; HEMOGLOBIN; HYDROXYCHLOROQUINE; LEFLUNOMIDE; LEVOCETIRIZINE; METHOTREXATE; METHYLPREDNISOLONE; PHENIRAMINE; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE;

ADULT; ANGIONEUROTIC EDEMA; ANKLE PAIN; BLOOD CELL COUNT; CASE REPORT; CHILL; DRUG WITHDRAWAL; ELECTROCARDIOGRAM; ERYTHEMA; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; HUMAN; KNEE PAIN; LETTER; NAUSEA; PAIN; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RIGOR; SCORING SYSTEM; SERUM SICKNESS; SINUS TACHYCARDIA; SWELLING; TACHYCARDIA; URTICARIA;

ANGIOEDEMA; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; MIDDLE AGED; SERUM SICKNESS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84857065028     PISSN: 17561841     EISSN: 1756185X     Source Type: Journal    
DOI: 10.1111/j.1756-185X.2011.01645.x     Document Type: Letter

References (11)

1. Kimby E (2005) Tolerability and safety of rituximab (MabThera). Cancer Treat Rev31, 456-73.
2. Campbell P, Marcus R (2003) Monoclonal antibody therapy for lymphoma. Blood Rev17, 143-52.
3. Biogen Idec Inc., Genentech, Inc. (2005) Rituximab Package Insert. Available on URL:
4. Goto S, Goto H, Tanoshima Ret al. (2009) Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura. Int J Hematol89, 305-9.
5. Mehsen N, Yvon CM, Richez C, Schaeverbeke T (2008) Serum sickness following a first rituximab infusion with no recurrence after the second one. Clin Exp Rheumatol26, 967.
6. DeMonaco NA, Jacobs SA (2007) Serum sickness in a patient with follicular lymphoma after rituximab andradioimmunotherapy with ibritumomab tiuxetan. Clin Nucl Med32, 933-4.
7. Disperati P, Hicks LK, Buckstein R (2007) Rituximab-induced serum sickness in a patient with follicular lymphoma. Leuk Lymphoma48, 1633-5.
8. Finger E, Scheinberg M (2007) Development of serum sickness-like symptoms after rituximab infusion in two patients with severe hypergammaglobulinemia. J Clin Rheumatol13, 94-5.
9. Todd DJ, Helfgott SM (2007) Serum sickness following treatment with rituximab. J Rheumatol34, 430-3.
10. Schutgens RE (2006) Rituximab-induced serum sickness. Br J Haematol135, 147.
11. Shipley D, Ormerod AD (2001) Drug-induced urticaria. Recognition and treatment. Am J Clin Dermatol2, 151-8.